EV
Eftychios Valeontis
View Eftychios's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Nov 2019 - Present · 5 years and 1 months
Quantitative Analyst, Vp
Dec 2020 - Present · 4 years
Quantitative Developer, Vp
Nov 2019 - Nov 2020 · 1 years
Senior Developer
Sep 2013 - Jan 2017 · 3 years and 4 months
Company Details
At Columbia Threadneedle Investments, we invest to make a difference in your world, and the wider world. Millions of people rely on us to manage their money and invest for their future; together they entrust us with $617/€582/£506 billion*. We are globally connected with a team of over 650 investment professionals providing diverse expertise, spanning almost every asset class and market. We are intense about research as we believe that original independent research makes investment decisions smarter. We have a responsible ethos as investment decisions today help define the future we all seek. Every day, we’re looking for opportunities to improve how we invest and what our clients experience; our focus on continuous improvement means that we never stand still. Whatever world you want, our purpose is to help you achieve it. For Professional Investors Only This material is for information only and does not constitute an offer or solicitation of an order to buy or sell any securities or other financial instruments, or to provide investment advice or services. Information contained on this page should not be seen as investment advice or a recommendation. Important disclosures: http://www.columbiathreadneedle.com/linkedin *AUM data as at 30 June 2023
Year Founded
1985
Social Media
LinkedinTwitter
Industry
Financial Services, Beleggingen, Rechtskundig en financieel
HQ Location
Cannon Place 78 Cannon Street London, EC4N 6AG, GB
Keywords
--
Discover More About Cleveland Clinic

Find verified contacts of Eftychios Valeontis in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.